Keyphrases
Drug Treatment
100%
Chronic Obstructive Pulmonary Disease
100%
30-day Readmission
100%
Matched Cohort Study
100%
Readmission Rates
40%
Salmeterol
40%
Pharmacological Treatment
40%
Fluticasone Propionate
40%
Budesonide
40%
Hospital Setting
20%
Patient Care
20%
Drug Trials
20%
Patient Demographics
20%
Medicare
20%
No Significant Difference
20%
Drug Type
20%
Public Health Risk
20%
Rural Areas
20%
Clinical Decisions
20%
Urban Hospitals
20%
Health Facts
20%
Cerner
20%
Marital Status
20%
Hospital Readmission
20%
Patient Management
20%
Combination Treatment
20%
Chronic Obstructive Pulmonary Disease Patient
20%
Payer Type
20%
Propensity Score Matching
20%
Hospital Location
20%
Length of Hospital Stay
20%
Hospital-associated
20%
Medicaid Patients
20%
Lung Disease
20%
Payers
20%
Chronic Obstructive Pulmonary Disease Treatment
20%
Chi-square Analysis
20%
Medicine and Dentistry
Drug Therapy
100%
Chronic Obstructive Pulmonary Disease
100%
Cohort Analysis
100%
Patient Care
50%
Salmeterol
50%
Fluticasone
50%
Budesonide/Formoterol
50%
Public Health
25%
Combination Therapy
25%
Drug Screening
25%
Medicare
25%
Marital Status
25%
Chi Square Test
25%
Treatment of Chronic Obstructive Pulmonary Disease
25%
Propensity Score Matching
25%
Silo-Filler's Disease
25%
Nursing and Health Professions
Drug Therapy
100%
Hospital Readmission
100%
Obstructive Lung Disease
100%
Cohort Analysis
100%
Patient Care
25%
Fluticasone/Salmeterol
25%
Budesonide/Formoterol
25%
Combination Therapy
12%
Length of Stay
12%
Drug Screening
12%
Propensity Score
12%
Medicare
12%
Cerner
12%
Chi Square Test
12%
Lung Disease
12%
Marital Status
12%
Hospital Setting
12%
Nutrition Policy
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Cohort Study
100%
Chronic Obstructive Lung Disease
100%
Budesonide Plus Formoterol
40%
Salmeterol
40%
Fluticasone
40%
Combination Therapy
20%
Drug Screening
20%
Lung Disease
20%
Phase IV
20%